arrow
I

Isabel Graupera

vall d'hebron institut de recerca (vhir)
H指数:49
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study

一般人群中肝纤维化的患病率(LiverScreen项目):一项多国欧洲队列研究

2026-04-090
PRE
The rate and predictors of recompensation in patients with decompensated cirrhosis due to metabolic dysfunction-associated liver disease (MASLD)

代谢功能障碍相关肝病(MASLD)引起的失代偿期肝硬化的再代偿速率及预测因素

2026-04-010
PRE
Marked Variation in Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Over 5 Years: A Community-Based Study Using Controlled Attenuation Parameter

代谢功能障碍相关脂肪性肝病5年内肝脂肪变程度的显著变化:一项基于社区研究使用控制衰减参数

2025-10-080
OAAI
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases. An international multicohort study.

PD-L1及慢性肝病患者细菌感染风险。一项国际多队列研究。

2025-09-180
OAAI
URINE PROTEOMICS IN CIRRHOSIS AND ACUTE KIDNEY INJURY: INSIGHTS INTO THE PATHOGENESIS OF HEPATORENAL SYNDROME

肝硬化及急性肾损伤中的尿液蛋白质组学:对肝肾综合征发病机制的见解

2025-08-130
PRE
CoQ imbalance drives reverse electron transport to disrupt liver metabolism

CoQ失衡驱动逆向电子传递以破坏肝脏代谢

NATURE
IF48.5
2025-05-280
PRE
Autoantibodies are associated with worse outcomes in MASLD

自身抗体与MASLD的不良预后相关

2025-05-010
OAAI
Trajectory analysis of hepatic stellate cell differentiation reveals metabolic regulation of cell commitment and fibrosis

肝星状细胞分化轨迹分析揭示了细胞命运决定和纤维化的代谢调控

2025-02-102
OA
Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
2025-01-010
OAAI
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

肝静脉压力梯度预测MASLD患者肝功能失代偿和肝脏相关死亡率的风险

2024-11-014
OAAI
Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 Individuals

筛查纤维化促进生活方式的改变: 4796个人的前瞻性队列研究

2024-05-0112
OAAI
Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling
2024-04-010
OAAI
Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
2023-10-017
OAAI
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

普通人群长期肝脏相关结局风险评分的制定、验证和预后评估: 一项多职业研究

LANCET
IF88.5
2023-09-0146
OAAI
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

神经母细胞瘤RAS病毒癌基因同源物 (n-ras) 缺乏加重肝损伤和纤维化

2023-08-101
OAAI
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease
2023-08-0163
OAAI
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries (vol 22, 1385, 2022)

LiverScreen项目: 欧洲国家普通人群中肝纤维化筛查的研究方案 (第22卷,1385,2022)

2023-05-220
OAAI